Joh. Wesling Klinikum Minden; Klinik fuer Hämatologie und Onkologie

Minden 32429

0 studies enrolling now · 1 studies all time

What they study most

Lymphoma

Studies at this site

• A Study of Polatuzumab Vedotin (DCDS4501A) in Combination With Rituximab or Obinutuzumab Plus Bendamustine in Participants With Relapsed or Refractory Follicular or Diffuse Large B-Cell Lymphoma — Completed